{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:46:38Z","timestamp":1761511598586},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,2,1]],"date-time":"1997-02-01T00:00:00Z","timestamp":854755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Medicine Today"],"published-print":{"date-parts":[[1997,2]]},"DOI":"10.1016\/s1357-4310(96)10058-7","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:51:50Z","timestamp":1027637510000},"page":"69-75","source":"Crossref","is-referenced-by-count":65,"title":["Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles"],"prefix":"10.1016","volume":"3","author":[{"given":"Derek T.","family":"O'Hagan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary S.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Van Nest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1357-4310(96)10058-7_bib1","author":"Plotkin","year":"1988"},{"key":"10.1016\/S1357-4310(96)10058-7_bib2","series-title":"Vaccine Design: the Subunit and Adjuvant Approach","first-page":"1","article-title":"Design considerations for subunit vaccines","author":"Powell","year":"1995"},{"key":"10.1016\/S1357-4310(96)10058-7_bib3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1128\/JVI.68.3.1418-1425.1994","article-title":"Antibody and cytotoxic T-cell responses to soluble hepatitis B virus (HBV) antigen in mice: implication for the pathogenesis of HBV-induced hepatitis","volume":"68","author":"Schirmbeck","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/S1357-4310(96)10058-7_bib4","series-title":"Vaccine Design: the Subunit and Adjuvant Approach","first-page":"229","article-title":"Adjuvant properties of aluminium and calcium compounds","author":"Gupta","year":"1995"},{"key":"10.1016\/S1357-4310(96)10058-7_bib5","first-page":"96","article-title":"Adjuvants \u2014a balance between toxicity and adjuvan-ticity","volume":"10","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib6","series-title":"Vaccine Research and Development","first-page":"89","article-title":"The use of muramyl peptides as vaccine adjuvants","author":"Ott","year":"1992"},{"key":"10.1016\/S1357-4310(96)10058-7_bib7","first-page":"CB112","article-title":"Detailed composition of natural MPL\u00ae immunostimulant","volume":"16C","author":"Myers","year":"1992","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/S1357-4310(96)10058-7_bib8","series-title":"Vaccine Design: the Subunit and Adjuvant Approach","first-page":"495","article-title":"Monophosphoryl lipid A as an adjuvant: past experiences and new directions","author":"Ulrich","year":"1995"},{"key":"10.1016\/S1357-4310(96)10058-7_bib9","series-title":"Vaccines 92","first-page":"35","article-title":"Structure\/function relationship in adjuvants from Quillaja saponaria Molina","author":"Kensil","year":"1992"},{"key":"10.1016\/S1357-4310(96)10058-7_bib10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0264-410X(94)80052-2","article-title":"Phase I trial of immunological adjuvant QS-21 with a GM2 ganglioside-KLH conjugate vaccine in patients with malignant melanoma","volume":"12","author":"Livingston","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-5699(90)90034-7","article-title":"Immunological adjuvants: a role for liposomes","volume":"11","author":"Gregoriadis","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1016\/S1357-4310(96)10058-7_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0304-4157(92)90004-T","article-title":"Immunologic aspects of liposomes, dpresentation and pro-cessing of liposomal protein and phospholipid antigens","volume":"1113","author":"Alving","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/S1357-4310(96)10058-7_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0264-410X(95)00253-W","article-title":"Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant","volume":"14","author":"Bengtsson","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(86)90402-3","article-title":"An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity","volume":"95","author":"Allison","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S1357-4310(96)10058-7_bib15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0264-410X(95)00089-J","article-title":"Enhancement of humoral response against human influenza vaccine with the simple submicron oil\/water emulsion adjuvant MF59","volume":"13","author":"Ott","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib16","series-title":"Vaccine Design: the Subunit and Adjuvant Approach","first-page":"277","article-title":"MF59: design and evaluation of a safe and potent adjuvant for human use","author":"Ott","year":"1995"},{"key":"10.1016\/S1357-4310(96)10058-7_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1749-6632.1993.tb35946.x","article-title":"Advances in influenza virus vaccine research","volume":"685","author":"Couch","year":"1993","journal-title":"Ann. New York Acad. Sci."},{"key":"10.1016\/S1357-4310(96)10058-7_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/0003-4819-122-12-199506150-00001","article-title":"A recombinant glycoprotein vaccine for her-pes simplex type 2: safety and immunogenicity","volume":"122","author":"Langenberg","year":"1995","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/S1357-4310(96)10058-7_bib19","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/infdis\/170.5.1288","article-title":"Clinical and immunologic responses to human immuno-deficiency virus (HIV) type I SF2 gp120 subunit vaccine combined with MF59 adjuvant with or without muramyl tripeptide dipalmitoyl phosphatidyl-ethanolamine in non HIV-infected human volunteers","volume":"170","author":"Kahn","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S1357-4310(96)10058-7_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/infdis\/174.2.387","article-title":"Mucosal antibodies to human cytomegalovirus glyco-protein b occur following both natural infection and immunization with human cytomegalovirus vaccines","volume":"174","author":"Wang","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S1357-4310(96)10058-7_bib21","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.4049\/jimmunol.153.9.4029","article-title":"Systemic cytokine profiles in BALB\/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants","volume":"153","author":"Valensi","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S1357-4310(96)10058-7_bib22","series-title":"Novel Delivery Systems for Oral Vaccines","first-page":"175","article-title":"Microparticles as oral vaccines","author":"O'Hagan","year":"1994"},{"key":"10.1016\/S1357-4310(96)10058-7_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BFb0043062","article-title":"Phagocytosis of polymer microspheres by macrophages","volume":"94","author":"Tabata","year":"1990","journal-title":"Adv. Polym. Sci."},{"key":"10.1016\/S1357-4310(96)10058-7_bib24","series-title":"Drug Carriers in Medicine","first-page":"237","article-title":"Lactide\/glycolide polymers used as surgical suture material, raw material for osteosynthesis and in sustained release of drugs","author":"Wise","year":"1979"},{"key":"10.1016\/S1357-4310(96)10058-7_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-3659(87)90074-5","article-title":"Prolonged delivery of peptides by microcapsules","volume":"6","author":"Maulding","year":"1987","journal-title":"J. Cont. Rel."},{"key":"10.1016\/S1357-4310(96)10058-7_bib26","first-page":"239","article-title":"Biodegradable microparticles as controlled release antigen delivery systems","volume":"73","author":"O'Hagan","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/S1357-4310(96)10058-7_bib27","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly (dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/S1357-4310(96)10058-7_bib28","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0264-410X(93)90387-D","article-title":"Long term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles","volume":"11","author":"O'Hagan","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0264-410X(91)90295-H","article-title":"Controlled release microparticles for vaccine devel-opment","volume":"9","author":"O'Hagan","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib30","first-page":"661","article-title":"Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly (lactide-co-glycolide) microparticles","volume":"81","author":"Maloy","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/S1357-4310(96)10058-7_bib31","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0264-410X(95)00184-3","article-title":"Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cyto-toxic T lymphocytes and CD4+ Th1 cells","volume":"13","author":"Moore","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib32","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0378-5173(92)90157-W","article-title":"Immunogenicity studies on diphtheria toxoid loaded biodegradable microspheres","volume":"85","author":"Singh","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/S1357-4310(96)10058-7_bib33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0168-3659(95)00052-A","article-title":"The preparation, characterization and pre-clinical evaluation of an orally administered HIV-1 vaccine, consisting of a branched synthetic peptide immunogen entrapped in controlled release microparticles","volume":"36","author":"O'Hagan","year":"1995","journal-title":"J. Cont. Rel."},{"key":"10.1016\/S1357-4310(96)10058-7_bib34","first-page":"S21","article-title":"Development of a single-shot subunit vaccine for HIV-1","volume":"10","author":"Cleland","year":"1994","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S1357-4310(96)10058-7_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0168-3659(90)90133-E","article-title":"Controlled vaccine release in the gut associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches","volume":"11","author":"Eldridge","year":"1991","journal-title":"J. Cont. Rel."},{"key":"10.1016\/S1357-4310(96)10058-7_bib36","first-page":"164","article-title":"Enhanced secretory IgA and systemic IgG after oral immunization with biodegradable microparticles","volume":"76","author":"Challacombe","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/S1357-4310(96)10058-7_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/IAI.64.2.489-494.1996","article-title":"Oral immunization with microencapsulated pertussis fimbriae induces protective immunity in mice","volume":"64","author":"Jones","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/S1357-4310(96)10058-7_bib38","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0264-410X(94)00008-B","article-title":"Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin","volume":"13","author":"Cahill","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib39","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/IAI.63.4.1195-1200.1995","article-title":"Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly (dl-lactide-co-glycolide) microspheres","volume":"63","author":"Shahin","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/S1357-4310(96)10058-7_bib40","first-page":"39","article-title":"Intranasal immunization with ricin toxoid (RT) vaccine encapsulated in polymeric microspheres against aerosol challenge","volume":"22","author":"Yan","year":"1995"},{"key":"10.1016\/S1357-4310(96)10058-7_bib41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.8493576","article-title":"Protection against vaginal SIV transmission with microencapsulated vaccine","volume":"260","author":"Marx","year":"1993","journal-title":"Science"},{"key":"10.1016\/S1357-4310(96)10058-7_bib42","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1128\/IAI.63.8.2880-2885.1995","article-title":"Humoral immunity to aerosolized staphylococcal entero-toxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres","volume":"63","author":"Tseng","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/S1357-4310(96)10058-7_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0264-410X(94)00029-M","article-title":"Mucosal IgA response to rec-tally administered antigen formulated in IgA-coated liposomes","volume":"13","author":"Zhou","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/S1357-4310(96)10058-7_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2958.1994.tb01266.x","article-title":"Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis","volume":"14","author":"Pizza","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/S1357-4310(96)10058-7_bib45","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/IAI.64.3.974-979.1996","article-title":"Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat labile enterotoxin as a mucosal adjuvant","volume":"64","author":"Di","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/S1357-4310(96)10058-7_bib46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nm0796-795","article-title":"A month-long effect from a single injection of microencapsulated human growth hormone","volume":"2","author":"Johnson","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/S1357-4310(96)10058-7_bib47","first-page":"11","article-title":"Structure and function of intestinal mucosal epithelium","author":"Kato","year":"1994"}],"container-title":["Molecular Medicine Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357431096100587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357431096100587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T20:31:53Z","timestamp":1681504313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357431096100587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["S1357431096100587"],"URL":"https:\/\/doi.org\/10.1016\/s1357-4310(96)10058-7","relation":{},"ISSN":["1357-4310"],"issn-type":[{"value":"1357-4310","type":"print"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}